Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Prognostic value of positron emission tomography using F-18-fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy.

Nakamoto Y, Eisbruch A, Achtyes ED, Sugawara Y, Reynolds KR, Johnston CM, Wahl RL.

Gynecol Oncol. 2002 Feb;84(2):289-95.

PMID:
11812089
[PubMed - indexed for MEDLINE]
2.

Positron emission tomography for prostate, bladder, and renal cancer.

Schöder H, Larson SM.

Semin Nucl Med. 2004 Oct;34(4):274-92. Review.

PMID:
15493005
[PubMed - indexed for MEDLINE]
3.

The role of PET/CT in the management of cervical cancer.

Mirpour S, Mhlanga JC, Logeswaran P, Russo G, Mercier G, Subramaniam RM.

AJR Am J Roentgenol. 2013 Aug;201(2):W192-205. doi: 10.2214/AJR.12.9830. Review.

PMID:
23883234
[PubMed - indexed for MEDLINE]
4.

FDG-PET parameters as prognostic factor in esophageal cancer patients: a review.

Omloo JM, van Heijl M, Hoekstra OS, van Berge Henegouwen MI, van Lanschot JJ, Sloof GW.

Ann Surg Oncol. 2011 Nov;18(12):3338-52. doi: 10.1245/s10434-011-1732-1. Epub 2011 May 3. Review.

PMID:
21537872
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Biological predictors of cervical cancer response to radiation therapy.

Klopp AH, Eifel PJ.

Semin Radiat Oncol. 2012 Apr;22(2):143-50. doi: 10.1016/j.semradonc.2011.12.009. Review.

PMID:
22385921
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk